Could fewer heart tests be safer for breast cancer patients?
NCT ID NCT06930521
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether breast cancer patients on HER2-targeted therapy can safely have fewer heart tests. Currently, patients get heart scans every three months, but most don't change treatment. Researchers will test a personalized schedule based on heart risk, comparing it to the standard approach in 300 patients. The goal is to reduce stress, delays, and costs without compromising heart or cancer outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a more personalized, less burdensome heart monitoring schedule for breast cancer patients, reducing unnecessary tests and healthcare costs.
- What could go wrong
- This is an early-stage study with only 300 participants, so results may not apply to all patients. There is a small risk that less frequent monitoring could miss early signs of heart damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Toronto General Hospital
RECRUITINGToronto, Ontario, M5G 2C4, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?